CClinicalTrials.gg
CompletedNCT04124757EURORELAXUpdated Jun 11, 2025Results posted

Impact of Deep Versus Standard Muscle Relaxation on Intra-operative Safety

An interventional study of Deep neuromuscular block in Neuromuscular Blockade, Rocuronium and Anesthetics, sponsored by Leiden University Medical Center. Completed at 8 sites in 4 countries. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-06-11.

Sponsored by Leiden University Medical Center · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
731
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Muscle relaxants are routinely applied during anesthesia to facilitate endotracheal intubation and to improve surgical working conditions. Several investigations have shown that a deep neuromuscular block (NMB) improves the surgical working conditions over a moderate NMB and effectively precludes sudden deterioration of the surgical field. However, whether the improvement of surgical working conditions translates into less intra- and postoperative complications remains uncertain. Small prospective or retrospective studies shown an decrease of the incidence of intraoperative adverse events and postoperative complications after a deep NMB. There is a need to confirm these outcome data prospectively, in a large number of patients and clinics and during a variety of surgical procedures.

Read the detailed description

Muscle relaxants are routinely applied during anesthesia to facilitate endotracheal intubation and to improve surgical working conditions. Several investigations have shown that a deep neuromuscular block (NMB) (post tetanic count (PTC) 1-2 twitches) improves the surgical working conditions over a moderate NMB (TOF count 1-3 twitches) and effectively precludes sudden deterioration of the surgical field. However, whether the improvement of surgical working conditions translates into less intra- and postoperative complications remains uncertain. A recent retrospective analysis of neuromuscular management during laparoscopic retroperitoneal surgery showed a reduced rate of unplanned 30 day readmissions when a deep NMB over a moderate NMB was applied (3.8% vs. 12.7%).In addition, a pooled analysis of 4 randomized controlled trials comparing different levels of intra-abdominal pressure and neuromuscular blockade during laparoscopic donor nephrectomy, showed a significant reduction in the incidence of intra-operative surgical complications from 12.6% with moderate NMB to 4.8% with deep NMB.

These previous observations were made in small prospective or retrospective studies. There is a need to confirm these outcome data prospectively, in a larger prospective trial for a variety of surgical procedures. We therefore propose a multi-center, randomized controlled trial, to study the effect of a deep NMB (PTC 1-2 twitches) versus standard NMB (single induction dose rocuronium) in a variety of laparoscopic surgical procedures on the incidence of intraoperative adverse events and postoperative outcome data.

In this study the effect of deep neuromuscular block compared to standard neuromuscular block on intra-operative adverse events during laparoscopic surgery using the CLASSIC score system is evaluated.

02

Conditions studied

  • Neuromuscular Blockade
  • Rocuronium
  • Anesthetics
  • Anesthesia Complication
  • Neuromuscular Blocking Agents
  • Surgery--Complications

Keywords

  • Laparoscopy
03

In context

Lead sponsor

Leiden University Medical Center is the lead sponsor of 326 studies on the registry; 106 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients scheduled for elective laparoscopic procedure with a complexity according to the BUPA classification for case complexity: 'MAJOR', 'MAJOR Plus or 'COMPLEX MAJOR'
  • ASA (merican society of anesthesiologists) class I-III
  • > 18 years of age
  • Ability to give oral and written informed consent

Exclusion criteria

Exclusion Criteria:

  • Low or intermediate complexity laparoscopic procedures (BUPA 'SIMPLE' or 'INTER')
  • Known or suspected neuromuscular disorders impairing neuromuscular function
  • Allergies to muscle relaxants, anesthetics or narcotics mentioned in paragraph 5.2
  • A (family) history of malignant hyperthermia
  • Women who are or may be pregnant or are currently breast feeding
  • Chronic use of any type of opioid or psychotropic drug
  • Use of NSAID's shorter than 5 days before surgery
  • Indication for rapid sequence induction
  • Contra-indication for sugammadex use (e.g. known sugammadex allergy or Glomerular Filtration Rate \<30 ml/min)
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Outcomes assessor)
Enrollment
731 participants (actual)

Study arms

  • No intervention
    Standard neuromuscular blockade

    Subjects will receive regular rocuronium induction dose, followed by bolus foses of 10 mg in case of insufficient conditions

  • Experimental
    Deep neuromuscular block

    Subjects will receive high dose rocuronium induction dose followed by continuous rocuronium administration, to achieve a depth of neuromuscular block of 1-2 twitches post tetanic count

    Other: Deep neuromuscular block

Interventions

  • OtherDeep neuromuscular block

    Deep neuromuscular block will be achieved with high dose rocuronium to achieve a depth of 1-2 twitches post tetanic count

    Also known as: High dose rocuronium

06

What researchers measure

Primary outcomes

  1. Classic Score>1

    The incidence of symptomatic intra-operative adverse events requiring intervention or treatment (ClassIntra®grade \>1) during laparoscopic surgery in the standard of care versus the deep NMB group, as scored by the attending surgeon and anesthesiologist at the end of every procedure. A recent update of the ClassIntra®grade also involved intraoperative adverse events related to anesthesia \[Gawria et al 2023\]. This study will use both the original classic scoring, as well as an adapted version of the updated classic scoring system. The Classic score; classification of intraoperative complications, is a 6 point scale ranging from no complications (0) to fatal complications (5).

    Time frame: Day of surgery

Secondary outcomes

  1. L-SRS (Leiden Surgical Rating Scale)

    To study the effect of deep neuromuscular block compared to standard neuromuscular block on peroperative surgical working conditions following the Leiden Surgical Rating scale (a 5 point scale, ranging from poor (1) to excellent (5) surgical conditions.

    Time frame: Day of surgery

  2. 30 Day Post-operative Complications

    To study the effect of deep neuromuscular block compared to standard neuromuscular block on 30 day post-operative complications according the Clavien-Dindo score en Comprehensive Complication Index and unplanned readmissions

    Time frame: 30 postoperative days

  3. Quality of Recovery (QoR)

    To study the effect of deep neuromuscular block compared to standard neuromuscular block on Quality of Recovery at post-operative day 1, 2 according to the Quality of Recovery-40

    Time frame: 2 postoperative days

  4. Quality of Life (QoL)

    To study the effect of deep neuromuscular block compared to standard neuromuscular block on Quality of life at post-operative day 30 Short Form-36

    Time frame: 30 postoperative days

07

Results

Posted Jun 11, 2025

Participant flow

Participant flow — Overall Study
MilestoneStandard Neuromuscular BlockadeDeep Neuromuscular Block
Started367364
Completed365363
Not completed21

Outcome measures

PrimaryClassic Score>1

The incidence of symptomatic intra-operative adverse events requiring intervention or treatment (ClassIntra®grade \>1) during laparoscopic surgery in the standard of care versus the deep NMB group, as scored by the attending surgeon and anesthesiologist at the end of every procedure. A recent update of the ClassIntra®grade also involved intraoperative adverse events related to anesthesia \[Gawria et al 2023\]. This study will use both the original classic scoring, as well as an adapted version of the updated classic scoring system. The Classic score; classification of intraoperative complications, is a 6 point scale ranging from no complications (0) to fatal complications (5).

Time frame:
Day of surgery
Reported as:
Number · participants
Classic Score>1
participantsStandard Neuromuscular BlockadeDeep Neuromuscular Block
Classic Score>16654
SecondaryL-SRS (Leiden Surgical Rating Scale)

To study the effect of deep neuromuscular block compared to standard neuromuscular block on peroperative surgical working conditions following the Leiden Surgical Rating scale (a 5 point scale, ranging from poor (1) to excellent (5) surgical conditions.

Time frame:
Day of surgery
Reported as:
Mean · units on a scale
L-SRS (Leiden Surgical Rating Scale)
units on a scaleStandard Neuromuscular BlockadeDeep Neuromuscular Block
L-SRS (Leiden Surgical Rating Scale)4.6 ± 0.54.9 ± 0.3
Secondary30 Day Post-operative Complications

To study the effect of deep neuromuscular block compared to standard neuromuscular block on 30 day post-operative complications according the Clavien-Dindo score en Comprehensive Complication Index and unplanned readmissions

Time frame:
30 postoperative days
Reported as:
Count of participants · Participants
30 Day Post-operative Complications
ParticipantsStandard Neuromuscular BlockadeDeep Neuromuscular Block
30 Day Post-operative Complications142139
SecondaryQuality of Recovery (QoR)

To study the effect of deep neuromuscular block compared to standard neuromuscular block on Quality of Recovery at post-operative day 1, 2 according to the Quality of Recovery-40

Time frame:
2 postoperative days

Results for this outcome have not been posted.

SecondaryQuality of Life (QoL)

To study the effect of deep neuromuscular block compared to standard neuromuscular block on Quality of life at post-operative day 30 Short Form-36

Time frame:
30 postoperative days

Results for this outcome have not been posted.

Adverse events

Collected over 1 month. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Standard Neuromuscular Blockade0/361 (0%)24/361 (6.6%)65/361 (18%)
Deep Neuromuscular Block0/362 (0%)23/362 (6.4%)51/362 (14.1%)
Most frequent serious events
Most frequent serious events
EventStandard Neuromuscular BlockadeDeep Neuromuscular Block
Unplanned readmissionSurgical and medical procedures24/36123/362
Most frequent other events
Most frequent other events
EventStandard Neuromuscular BlockadeDeep Neuromuscular Block
postoperative nausea vomitingGastrointestinal disorders65/36151/362

Baseline characteristics

Age, Continuous
Age, Continuous(year)Standard Neuromuscular BlockadeDeep Neuromuscular BlockTotal
Mean58.4 ± 13.758.0 ± 13.558.2 ± 13.6
Sex: Female, Male
Sex: Female, Male(Participants)Standard Neuromuscular BlockadeDeep Neuromuscular BlockTotal
Female150139289
Male212222434
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Standard Neuromuscular BlockadeDeep Neuromuscular BlockTotal
Hispanic or Latino000
Not Hispanic or Latino000
Unknown or Not Reported362361723
08

Study locations

8 sites
  • Université De Lorraine
    Nancy, Meurthe-et-Moselle 54000, France
  • Istituto Nazionale Dei Tumori
    Milano, 20133, Italy
  • RadboudUMC
    Nijmegen, Gelderland 6525GA, Netherlands
  • LUMC
    Leiden, Zuid-Holland 2333ZA, Netherlands
  • Noordwest ziekenhuis groep
    Alkmaar, 1815 JD, Netherlands
  • Netherlands Cancer institute
    Amsterdam, 1066 CX, Netherlands
  • Canisius Wilhelmina Ziekenhuis
    Nijmegen, 6532 SZ, Netherlands
  • Hospital Universitari I Politecnic La Fe
    Valencia, 46026, Spain
09

References and documents

Publications

  • Boon M, Martini C, Yang HK, Sen SS, Bevers R, Warle M, Aarts L, Niesters M, Dahan A. Impact of high- versus low-dose neuromuscular blocking agent administration on unplanned 30-day readmission rates in retroperitoneal laparoscopic surgery. PLoS One. 2018 May 23;13(5):e0197036. doi: 10.1371/journal.pone.0197036. eCollection 2018. PubMed 29791482 ↗
  • Torensma B, Martini CH, Boon M, Olofsen E, In 't Veld B, Liem RS, Knook MT, Swank DJ, Dahan A. Deep Neuromuscular Block Improves Surgical Conditions during Bariatric Surgery and Reduces Postoperative Pain: A Randomized Double Blind Controlled Trial. PLoS One. 2016 Dec 9;11(12):e0167907. doi: 10.1371/journal.pone.0167907. eCollection 2016. PubMed 27936214 ↗
  • Martini CH, Boon M, Bevers RF, Aarts LP, Dahan A. Evaluation of surgical conditions during laparoscopic surgery in patients with moderate vs deep neuromuscular block. Br J Anaesth. 2014 Mar;112(3):498-505. doi: 10.1093/bja/aet377. Epub 2013 Nov 15. PubMed 24240315 ↗
  • Rosenthal R, Hoffmann H, Clavien PA, Bucher HC, Dell-Kuster S. Definition and Classification of Intraoperative Complications (CLASSIC): Delphi Study and Pilot Evaluation. World J Surg. 2015 Jul;39(7):1663-71. doi: 10.1007/s00268-015-3003-y. PubMed 25665678 ↗
  • Madsen MV, Scheppan S, Mork E, Kissmeyer P, Rosenberg J, Gatke MR. Influence of deep neuromuscular block on the surgeons assessment of surgical conditions during laparotomy: a randomized controlled double blinded trial with rocuronium and sugammadex. Br J Anaesth. 2017 Sep 1;119(3):435-442. doi: 10.1093/bja/aex241. PubMed 28969327 ↗
  • Ozdemir-van Brunschot DMD, Braat AE, van der Jagt MFP, Scheffer GJ, Martini CH, Langenhuijsen JF, Dam RE, Huurman VA, Lam D, d'Ancona FC, Dahan A, Warle MC. Deep neuromuscular blockade improves surgical conditions during low-pressure pneumoperitoneum laparoscopic donor nephrectomy. Surg Endosc. 2018 Jan;32(1):245-251. doi: 10.1007/s00464-017-5670-2. Epub 2017 Jun 22. PubMed 28643056 ↗
  • Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004 Aug;240(2):205-13. doi: 10.1097/01.sla.0000133083.54934.ae. PubMed 15273542 ↗
  • Honing M, Reijnders-Boerboom G, Dell-Kuster S, van Velzen M, Martini C, Valenza F, Proto P, Cambronero OD, Broens S, Panhuizen I, Roozekrans M, Fuchs-Buder T, Boon M, Dahan A, Warle M. The impact of deep versus standard neuromuscular block on intraoperative safety during laparoscopic surgery: an international multicenter randomized controlled double-blind strategy trial - EURO-RELAX TRIAL. Trials. 2021 Oct 26;22(1):744. doi: 10.1186/s13063-021-05638-2. PubMed 34702332 ↗

Study documents

  • Protocol and statistical analysis plan · Jun 29, 2021

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: Yes — Protocol and SAP will be published before start study. CSR will be reported after article publication in a peer reviewed journal.

Supporting information: Study protocol, Sap

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 11, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT04124757
Lead sponsor
Leiden University Medical Center
Collaborators
Merck Sharp & Dohme LLC
Responsible party
Martijn Boon (Prinicipal Investigator, Leiden University Medical Center) — Principal investigator
First posted
Oct 11, 2019
Start date
Feb 11, 2020
Primary completion
Jun 1, 2024
Completion
Jun 1, 2024
Results posted
Jun 11, 2025
Last update
Jun 11, 2025

Study contacts

Monique van Velzen, PhD
principal investigator · LUMC

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion